CTLA4 and neoplasm: Immunosuppression has been discovered to be common in the TME due to the lack of antigens in tumor cells and the lack of immunosuppression produced by immune system suppressive signaling pathways such as PD-1/PD-L1 and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) (36).